Skip to content

The pharmacokinetics of single dose of alstonia-leaf alkaloids capsule and alstonia-leaf tablet on Chinese healthy vonlunteers

The pharmacokinetics of single dose of alstonia-leaf alkaloids capsule and alstonia-leaf tablet on Chinese healthy vonlunteers

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006976
Enrollment
Unknown
Registered
2015-08-26
Start date
2015-08-28
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

five:drug intervention

Sponsors

Xiyuan Hospital,CACMS
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged btween 18 to 50 years, half male and female;BMI between 19 to 25, men's weight>50kg, women's weight>45kg, similar body weight within the same batch; no positive signs of physical examination; no clinically abnormity of laboratory inspection and ECG test; informed consent and volunteered to participate the trial.

Exclusion criteria

Exclusion criteria: substance abuser, heavy smoker, alcoholist; subjects who had all sorts of drugs, health care products (including traditional Chinese medicine, homemade wine, etc.) two weeks ago;subjects who participated in clinical trials in recent 4 weeks; subjects who had medication with known organ lesions within 3 months or in current drug use;subjects who donated blood or received blood sampling in clinical trial within 3 months; subjects who had severe disease (including critical illness, infectious disease, food and drug allergy); subjects who had drug allergy history or with allergic constitution;subjects who had medical history of heart, liver, kidney, digestive tract or nervous and mental system;subjects with positive infection indices; pregnant, breastfeeding and menstrual women, or women planning pregnancy within 3 months; subjects with gastrointestinal disease or received gastrointestinal operation which may influence the drug absorption; subjects who had bad compliance by investigator's judgement.

Design outcomes

Primary

MeasureTime frame
blood routine test;urine routine test;stool routine test;blood biochemistry test;ECG test;pregnancy test;demography information;vital signs;Tmax;Cmax;AUC;t1/2;CL;MRT;Vd;Ke;

Countries

China

Contacts

Public ContactRui Gao
ruigao@126.com+86 010-62835653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026